Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029331498> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3029331498 abstract "e24016 Background: ICI therapy has become the standard of care for the treatment of most types of advanced lung cancer with an average age at diagnosis of 70 years old (yo). The objectives of this study were to describe the demographics and practice patterns of real-world ICI usage in lung cancer patients > 70 yo. Methods: We conducted a retrospective, observational cohort study utilizing statistically deidentified data sourced from CancerLinQ Discovery® ( www.cancerlinq.org/solutions/researchers ): Lung Cancer (2014-2019), October, 2018 data set release, American Society of Clinical Oncology’s (ASCO’s) CancerLinQ LLC. Of the 1632 patients in this data release, only those patients who received a single agent ICI of nivolumab, pembrolizumab or atezolizumab and had a known birthdate were included in the analyses. Results: The majority of the 1632 patients in the data set were male (46.9%) and Caucasian (43.4%), although a substantial percentage of patient Gender and Race data was not known (14.5% and 43.1% respectively). The majority of the patients were treated in the southern part of the United States (52.6%) and the median ages for adenocarcinoma and squamous cell carcinoma histologies were 66 and 70, respectively, with interquartile ranges of 59-74 and 63-76. In the analyses, the major delineator was age at 70 yo, where age is based on when a patient received their first ICI dose. For patients < 70 yo, the mean (max) number of cycles in patients who received atezolizumab, nivolumab and pembrolizumab was 5.4 (24), 8.7 (62) and 7.7 (32), respectively and for patients > 70 yo was 4.6 (30), 8.1 (64) and 6.5 (23), respectively. The median overall survival for patients < 70 yo who received atezolizumab, nivolumab and pembrolizumab was 24, 12 and 24 months, respectively and for patients > 70 yo was 24, 12 and 18 months, respectively. Conclusions: The number of cycles and overall survival reported in this real-world dataset were similar between patients older and younger than 70 yo with lung cancer treated with ICI. Limitations included decreased power for multivariate analysis due to suppressed data elements which has been improved in more recent data releases." @default.
- W3029331498 created "2020-06-05" @default.
- W3029331498 creator A5000456383 @default.
- W3029331498 creator A5011034688 @default.
- W3029331498 creator A5019189402 @default.
- W3029331498 creator A5025514406 @default.
- W3029331498 creator A5035436218 @default.
- W3029331498 creator A5055785853 @default.
- W3029331498 creator A5071496344 @default.
- W3029331498 creator A5077057137 @default.
- W3029331498 creator A5081726531 @default.
- W3029331498 date "2020-05-20" @default.
- W3029331498 modified "2023-10-05" @default.
- W3029331498 title "Treatment trends with immune checkpoint inhibitor (ICI) therapy in older adults with lung cancer." @default.
- W3029331498 doi "https://doi.org/10.1200/jco.2020.38.15_suppl.e24016" @default.
- W3029331498 hasPublicationYear "2020" @default.
- W3029331498 type Work @default.
- W3029331498 sameAs 3029331498 @default.
- W3029331498 citedByCount "0" @default.
- W3029331498 crossrefType "journal-article" @default.
- W3029331498 hasAuthorship W3029331498A5000456383 @default.
- W3029331498 hasAuthorship W3029331498A5011034688 @default.
- W3029331498 hasAuthorship W3029331498A5019189402 @default.
- W3029331498 hasAuthorship W3029331498A5025514406 @default.
- W3029331498 hasAuthorship W3029331498A5035436218 @default.
- W3029331498 hasAuthorship W3029331498A5055785853 @default.
- W3029331498 hasAuthorship W3029331498A5071496344 @default.
- W3029331498 hasAuthorship W3029331498A5077057137 @default.
- W3029331498 hasAuthorship W3029331498A5081726531 @default.
- W3029331498 hasConcept C119060515 @default.
- W3029331498 hasConcept C121608353 @default.
- W3029331498 hasConcept C126322002 @default.
- W3029331498 hasConcept C143998085 @default.
- W3029331498 hasConcept C144024400 @default.
- W3029331498 hasConcept C149923435 @default.
- W3029331498 hasConcept C167135981 @default.
- W3029331498 hasConcept C2775949291 @default.
- W3029331498 hasConcept C2776256026 @default.
- W3029331498 hasConcept C2777701055 @default.
- W3029331498 hasConcept C2780030458 @default.
- W3029331498 hasConcept C2780057760 @default.
- W3029331498 hasConcept C2780084366 @default.
- W3029331498 hasConcept C2781182431 @default.
- W3029331498 hasConcept C71924100 @default.
- W3029331498 hasConcept C72563966 @default.
- W3029331498 hasConceptScore W3029331498C119060515 @default.
- W3029331498 hasConceptScore W3029331498C121608353 @default.
- W3029331498 hasConceptScore W3029331498C126322002 @default.
- W3029331498 hasConceptScore W3029331498C143998085 @default.
- W3029331498 hasConceptScore W3029331498C144024400 @default.
- W3029331498 hasConceptScore W3029331498C149923435 @default.
- W3029331498 hasConceptScore W3029331498C167135981 @default.
- W3029331498 hasConceptScore W3029331498C2775949291 @default.
- W3029331498 hasConceptScore W3029331498C2776256026 @default.
- W3029331498 hasConceptScore W3029331498C2777701055 @default.
- W3029331498 hasConceptScore W3029331498C2780030458 @default.
- W3029331498 hasConceptScore W3029331498C2780057760 @default.
- W3029331498 hasConceptScore W3029331498C2780084366 @default.
- W3029331498 hasConceptScore W3029331498C2781182431 @default.
- W3029331498 hasConceptScore W3029331498C71924100 @default.
- W3029331498 hasConceptScore W3029331498C72563966 @default.
- W3029331498 hasFunder F4320307765 @default.
- W3029331498 hasLocation W30293314981 @default.
- W3029331498 hasOpenAccess W3029331498 @default.
- W3029331498 hasPrimaryLocation W30293314981 @default.
- W3029331498 hasRelatedWork W11003051 @default.
- W3029331498 hasRelatedWork W16482145 @default.
- W3029331498 hasRelatedWork W1671086 @default.
- W3029331498 hasRelatedWork W17183283 @default.
- W3029331498 hasRelatedWork W18181725 @default.
- W3029331498 hasRelatedWork W20825895 @default.
- W3029331498 hasRelatedWork W3586763 @default.
- W3029331498 hasRelatedWork W3852933 @default.
- W3029331498 hasRelatedWork W21369385 @default.
- W3029331498 hasRelatedWork W7982398 @default.
- W3029331498 isParatext "false" @default.
- W3029331498 isRetracted "false" @default.
- W3029331498 magId "3029331498" @default.
- W3029331498 workType "article" @default.